Publications by authors named "Alessandro Pandolfo"

Claim this Profile
T
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco).
Valentina Morena, Federico Conti, Dario Cattaneo, Benedetta Trentacapilli, Martina Bottanelli, Alessandro Pandolfo

J Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics).
Sara Tordi, Elena Ricci, Luca Mezzadri, Stefania Piconi, Stefania Cicalini, Alessandro Pandolfo

New Microbiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort.
Alessandro Soria, Francesca Graziano, Giulia Ghilardi, Giuseppe Lapadula, Daniela Dalla Gasperina, Alessandro Pandolfo

Heliyon· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis in Immunocompromised Patients Treated During Omicron Sublineages Diffusion. Real-Life Experience from ASST Lecco.
Federico Conti, Silvia Pontiggia, Valentina Morena, Francesca Alberton, Flavia Badalucco, Alessandro Pandolfo

Am J Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
Marco Franzetti, Andrea Forastieri, Noemi Borsa, Alessandro Pandolfo, Chiara Molteni

J Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Infections.
Guido Granata, Nicola Petrosillo, Lucia Adamoli, Michele Bartoletti, Alessandro Bartoloni, Alessandro Pandolfo

J Clin Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.
Marco Franzetti, Ugo Pozzetti, Manuela Carugati, Alessandro Pandolfo, Chiara Molteni

Int J Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Mediated Immunity in HIV-Infected Males With Human Papillomavirus-Related Anal Dysplastic Lesions.
Camilla Tincati, Veronica Rainone, Laura Comi, Alessandro Pandolfo, Ambra Barco

Clin Infect Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients: role of cART and gender.
Elisa Suardi, Francesca Bai, Laura Comi, Alessandro Pandolfo, Marco Rovati

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV Infection in a Cohort of HIV-Positive Men and Women: Prevalence of Oncogenic Genotypes and Predictors of Mucosal Damage at Genital and Oral Sites.
Giulia Marchetti, Laura Comi, Teresa Bini, Marco Rovati, Francesca Bai, Alessandro Pandolfo

J Sex Transm Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive highly active antiretroviral therapy.
Francesca Bai, Giusi M Bellistrì, Camilla Tincati, Alessia Savoldi, Alessandro Pandolfo

AIDS· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis